Loading...
Loading...
TMDX| Name | Value |
|---|---|
| Revenues | 108.8M |
| Cost of Revenue | 47.9M |
| Gross Profit | 60.8M |
| Operating Expense | 56.9M |
| Operating I/L | 3.9M |
| Other Income/Expense | 0.3M |
| Interest Income | 3.3M |
| Pretax | 4.2M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | 4.2M |
TransMedics Group, Inc. is a medical technology company specializing in organ transplant therapy. The company's main revenue source comes from its Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS replicates near-physiologic conditions for donor organs outside of the human body, offering solutions for lung, heart, and liver transplants. The OCS LUNG preserves standard criteria donor lungs for double-lung transplantation, OCS Heart provides extracorporeal perfusion and preservation of donor hearts, and OCS Liver is designed for the preservation of donor livers.
